1. Medtech Insight
  2. >>Business
  3. >>Strategy

InPhact Inc.

InPhact aims to combine teleradiology with picture archiving and communications systems (PACS). The teleradiology services use the web to get images to radiologists in diagnostic form and to referring physicians in review form. Unlike the new applications service providers (ASPs), InPhact goes further, not only managing the transmission and storage of images on line, but also the on-line transmission of other radiology services, such as billing, data-collection, transcription. The four-year-old company has raised $14 million, and includes among its investors GE Medical Systems and MDS Capital.

In the mid-1990s, teleradiology held promise as a way of connecting hospitals with clinics and radiologists in remote locations. Teleradiology would allow managed care organizations to select high-quality providers at low cost and keep services and dollars within their systems. It was also convenient for general radiologists to provide night, weekend, and vacation coverage and to allow them to participate on weekends or evenings in making initial emergency diagnoses at home. The radiologists would still have to go to the hospital, but not in such a rush.

Jeffrey Landman, MD, a successful neuroradiologist and founder and chairman of two outpatient imaging centers, was experimenting with beta sites...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

Surgical Robotics CEOs Talk Metrics For Success, Valuations, Competition And IPO Outlook

 
• By Marion Webb

Leaders of robotic systems companies Distalmotion, Neocis and Noah Medical discussed success metrics, competition and funding. Institutional investors are focusing on utilization, procedure rates and a clear path to profitability as the IPO window reopens, BTIG analyst Ryan Zimmerman said.

Dxcover Launches US Operations With New Headquarters In Tennessee

 
• By Natasha Barrow

Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.

Fallouh Healthcare Receives Grant Funding From Innovate UK

 
• By Natasha Barrow

Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices

 
• By Natasha Barrow

Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.

More from Business

Mexico’s New Procurement Rules Aim To Increase Healthcare Investment, But May Face Legal Trouble

 
• By Francesca Bruce

Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.

Will Kennedy And Makary Come To Terms On User Fees During Next Round Of MDUFA Negotiations?

 
• By Brian Bossetta

It’s no secret that Marty Makary and Robert F. Kennedy Jr. have a different take on user fees, with Makary viewing them as a funding necessity and Kennedy as a corrupting influence. But will they find a way to strike a balance during the next MDUFA reauthorization talks so each can claim victory?

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices

 
• By Natasha Barrow

Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.